BioInnovation Capital is a venture capital firm in Massachusetts, United States that invests in businesses in the life science and healthcare-related sectors. Founded in 2010 in Cambridge, Massachusetts, this company invests in early stage and late stage ventures. The company's notable investment portfolio includes Avexegen, Cereius, Epiodyne, Graphwear, Mitokinin, Nocion Therapeutics, Pandion Therapeutics, etc.
BioInnovation Capital is actively seeking new investments and as of December 2019, the company made a total of 7 investments in which 3 of them are lead investments.
A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.
QurAlis is a biotechnology company developing treatments for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
GraphWear Technologies is a San Francisco-based company.
Associated investment funds
Eric W. Linsley
Managing General Partner
Documentaries, videos and podcasts